Compare Cardinal Health Inc (CAH) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Exxon Mobil Corporation — how do they compare? Cardinal Health Inc trades at $234.04 (market cap $55.88B), while Exxon Mobil Corporation trades at $159.14 (market cap $657.08B). The key difference: Exxon Mobil Corporation is far larger — about 11.8× Cardinal Health Inc's market cap, and Exxon Mobil Corporation pays the higher dividend (2.58%). Which is the better fit depends on your goals.
| CAH | XOM | |
|---|---|---|
Market Cap | $55.88B | $657.08B |
Sector | Health | Energy |
52-Week High | $240.26 | $171.52 |
52-Week Low | $146.04 | $106.49 |
Enterprise Value | $59.91B | $688.86B |
Dividend Yield | 0.86% | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $235.3, down 0.79% on the day, but remains near its 52-week high. The stock exhibits a bullish technical signal with consistent earnings beats in recent quarters, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue for fiscal 2025 was $222.58 billion, with net income reaching $1.56 billion. Analyst consensus is strongly positive, with 18 buys and a $266.43 price target, reflecting confidence in the company's pharmaceutical and specialty business growth.
The outlook for CAH is favorable, driven by robust earnings performance and optimistic fiscal 2027 guidance. Key opportunities include sustained demand for specialty drugs and operational efficiency gains. Risks involve high debt levels, with a debt-to-asset ratio of 16.09 in 2025, and competitive pressures in the healthcare distribution sector. Investors should weigh strong analyst support against balance sheet leverage and market volatility.
ExxonMobil (XOM) trades at $159.8, up 0.01% on the day, with a bullish technical signal and strong cash flow from operations of $52.0 billion in 2025. Recent earnings show mixed results, with a Q2 2026 miss but beats in prior quarters. The company maintains a solid balance sheet with a debt-to-asset ratio of 8.42% and continues shareholder returns via dividends, including the recent $1.03 per share payout.
XOM offers stable income with a 12.55% ROE and analyst consensus price target of $163.71, suggesting modest upside. Risks include declining revenue trends and oil price volatility, but low breakeven costs in the Permian Basin provide resilience. Institutional sentiment is cautiously optimistic, with 38.89% of analysts rating it a buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
